1. 2020

   In FY 2019, the Leadership Education in Adolescent Health (LEAH) program provided interdisciplinary leadership training to 2,197 health and related professionals at the graduate and postgraduate levels; enhanced the knowledge and skills of nearly 30,000 practicing professionals through the provision of 538 continuing education events; and strengthened the capacity of Title V and other MCH partners through 650 technical assistance activities to 136,660 recipients in local, state, and community entities.
   In FY 2020, the Strengthen the Evidence in Maternal and Child Health Program provided 44 technical assistance (TA) sessions to states and jurisdictions, including several regional TA sessions, topic-specific TA, and TA to all Pacific Basin and Atlantic jurisdictions; worked extensively with a team of expert reviewers to publish two Evidence Analysis Reports, for updates of National Performance Measure (NPM) Online Toolkits, and for TA requests; engaged 16 experts in the webinar development of evidence-based, informed strategies for the 15 Title V national performance measures, made available to all Title V states and jurisdictions’. The heritable disorders program has supported the widespread adoption of SCID newborn screening since 2014. In 2012, only six states screened for SCID. By 2018, all 50 states and 3 U.S. territories screen for SCID. Despite the success of broad SCID newborn screening, gaps remain in optimizing outcomes for infants with SCID that is detected by newborn screening. Additionally, almost 50% of states have implemented the four new conditions (Pompe [2015], X-ALD [2016], MPS I [2016], and SMA [2018]) added to the recommended screening panel since 2015.

2. 2021

   The Heritable Disorders Program has supported the widespread adoption of newborn screening since 2008. For example, in 2012, only six states screened for severe combined immunodeficiency (SCID). By 2018, all 50 states and 3 U.S. territories screen for SCID. Additionally, more than 50% of states have implemented four new conditions added to the recommended screening panel since 2013, including Pompe disease, X-linked adrenoleukodystrophy, Mucopolysaccharidosis type I, and Spinal Muscular Atrophy. Screening and Treatment for Maternal Depression and Related Behavioral Disorders programs improved short- and intermediate-term outcomes in training, consultation, and screening services. Awardees trained 1,085 providers in FY 2020, an increase from 160 providers trained in FY 2019. Providers received expert consultation for 7,448 pregnant and postpartum women in FY 2020, of which 47% lived in rural/underserved areas, an increase from 233 pregnant and postpartum women in FY 2019, of which 30% lived in rural/underserved areas. The number of pregnant and postpartum women screened for depression by participating providers increased from 4,053 in FY 2019 to 24,518 in FY 2021.

   In FY 2021, the Supporting Fetal Alcohol Spectrum Disorder Screening and Intervention Program enrolled 10 prenatal and 12 pediatric practices within 14 health centers in seven states in their 10-month Project Echo training program. Five of the enrolled health centers serve rural, 9 serve urban, and 3 serve tribal communities. At the mid-point survey, a high proportion of participants reported: increased knowledge about screening for Prenatal Alcohol Exposure (PAE) both during pregnancy and among children with possible FASD; improved self-efficacy to screen for PAE and counsel families about both PAE and FASD; and increased practice of screening for, and counseling patients with alcohol use during pregnancy and screening for PAE among children with suspected FASD.

3. 2022

   The Heritable Disorders Program has supported the widespread adoption of newborn screening since 2008. For example, in 2012, only six states screened for severe combined immunodeficiency (SCID). By 2018, all 50 states and 3 U.S. territories screen for SCID. Currently, all states screen for at least 31 core conditions on the Recommended Uniform Screening Panel (RUSP). Across the U.S., 40 out of 53 state newborn screening programs screen for 90% or more of the core conditions on the RUSP. . The MMHSUD program improved short- and intermediate-term outcomes in training, consultation, and screening services. Awardees trained 1,875 providers in FY 2022 compared to 782 in FY 2021. The number of providers using the MMHSUD program for consultation and care coordination support services for treatment and referral of pregnant and postpartum women with behavioral health conditions increased from 584 in FY 2021 to 824 in FY 2022.

   In FY 2022, the FASD Screening and Intervention program completed their first learning collaborative cohort which included 10 prenatal and 12 pediatric practices within 14 health centers in 7 states. The program also enrolled their second cohort which included 11 prenatal and 11 pediatric practices within 16 health centers in seven states. The combined cohorts included health centers serving 9 rural, 21 urban, and 7 tribal communities. Participants from the first cohort reported increased knowledge about screening for Prenatal Alcohol Exposure (PAE) both during pregnancy and among children with possible FASD; improved self-efficacy to screen for PAE and counsel families about both PAE and FASD; and increased practice of screening for, and counseling patients with alcohol use during pregnancy and screening for PAE among children with suspected FASD.

   Birthing facilities in all 50 states and D.C. are implementing AIM patient safety bundles (PSBs). As of February 2023, there are: • 1,917 birthing facilities participating in AIM. • 25 states engaged in widespread implementation of AIM PSBs • 7 states are implementing targeted quality improvement projects • 29 states implementing the Obstetric Hemorrhage bundle • 34 implementing the Severe Hypertension in Pregnancy bundle, and • 27 states implementing the Care for Pregnant and Postpartum People with Substance Use Disorder bundle.
   In June 2023, AIM launched the Obstetric Emergency Readiness Resource Kit, for use by teams in healthcare settings that may not typically provide obstetric services or frequently care for people experiencing obstetric emergencies.

   Since 2019, the State Maternal Health Innovation awardees have established Maternal Health Task Forces that regularly convene multidisciplinary stakeholders; created and are implementing a strategic plan that incorporates activities from the state’s most recent Title V Needs Assessment; and reported state-level data surveillance on maternal mortality and severe maternal morbidity for three years in their Maternal Health Annual Reports.

   Across 21 states in FY 2021, the PMHCA program achieved the following:
   • Over 6,700 primary care providers enrolled in a statewide or regional PMHCA program. • Over 2,000 providers used consultation and care coordination support services • Over 8,200 children and adolescents were served by Pediatric primary care providers who contacted the pediatric mental health team.

   Accomplishments from the MCH Research Networks in FY 2021 include: • Completed 104 studies on a broad range of maternal, child, and family health topics • Enrolled 13,998 participants in primary research studies across 475 research sites across the country, and included 2,822,373 participants in secondary data analyses • Published 75 peer-reviewed manuscripts in leading scholarly journals

4. 2023

   The Heritable Disorders program has supported the widespread adoption of newborn screening since 2008. For example, in 2012, only six states screened for severe combined immunodeficiency (SCID). By 2018, all 50 states and 3 U.S. territories screen for SCID. Currently, all states screen for at least 32 core conditions on the Recommended Uniform Screening Panel (RUSP). Across the U.S., 40 out of 53 state newborn screening programs screen for 92% or more of the core conditions on the RUSP.

   In FY 2023, the MMHSUD program trained 899 providers who sought and received expert consultation for 1,511 pregnant and postpartum women. Statewide programs are available in Colorado, Kansas, Kentucky, Louisiana, Missouri, Mississippi, Montana, North

   Carolina, Tennessee, Texas, Vermont, and West Virginia. There is also a regional program in Los Angeles County, California.

   In FY 2023, the FASD Screening and Intervention program enrolled 16 community health centers in their second learning collaborative cohort. This included 11 prenatal practices and 11 pediatric practices from 7 states (IL, ND, SD, MN, MA, RI, ME). Six of the 22 practices are tribal health clinics and 7 are rural clinics. The third learning collaborative cohort (pediatric group) commenced in September 2023 and enrolled 15 health systems, including 13 practices from 13 states (CT, ME, MA, MN, NJ, ND, OH, PA, SD, TX, VT, VA, WA). The prenatal group from the third cohort will begin in February 2024. Participants from the first cohort reported increased knowledge about screening for Prenatal Alcohol Exposure (PAE) both during pregnancy and among children with possible FASD; improved self-efficacy to screen for PAE and counsel families about both PAE and FASD; and increased practice of screening for, and counseling patients with alcohol use during pregnancy and screening for PAE among children with suspected FASD.

   As of August 2023, there were 1,996 birthing facilities in 49 states and D.C. participating in the Alliance for Innovation on Maternal Health (AIM), representing 74.1% of all birthing facilities in those states and jurisdictions. Currently, there are eight patient safety bundles that AIM state enrollees can choose to implement in birthing facilities, according to their needs and priorities: 1) Obstetric hemorrhage, 2) Severe hypertension in pregnancy, 3) Safe reduction of primary Cesarean birth, 4) Cardiac conditions in obstetric care, 5) Care for pregnant and postpartum people with substance use disorder, 6) Perinatal mental health conditions, 7) Postpartum discharge transition, and 8) Sepsis in obstetric care. Patient safety bundles are collections of evidence-informed best practices, developed by multidisciplinary experts, for birthing facilities on topics related to causes of maternal mortality and severe maternal morbidity. The bundle elements are actionable steps that are implemented through rapid quality improvement cycles and can be adapted to a variety of birthing facilities and resource settings.

   Since 2019, the State Maternal Health Innovation awardees have established Maternal Health Task Forces that regularly convene multidisciplinary stakeholders; created and are implementing a strategic plan that incorporates activities from the state’s most recent Title V Needs Assessment; and reported state-level data surveillance on maternal mortality and severe maternal morbidity for three years in their Maternal Health Annual Reports. As of 2024, organizations are carrying out this work in 42 states and the District of Columbia.

   Across 47 awardees in FY 2023, the PMHCA program achieved the following:

   Over 10,300 providers used consultation and care coordination support services.

   Over 28,500 children and adolescents were served by pediatric primary care and other providers who contacted the pediatric mental health team.

   Accomplishments from the MCH Research Networks in FY 2021 include:

   Completed 104 studies on a broad range of maternal, child, and family health topics

   Enrolled 13,998 participants in primary research studies across 475 research sites across the country, and included 2,822,373 participants in secondary data analyses

   Published 75 peer-reviewed manuscripts in leading scholarly journals

Single Audit Applies (2 CFR Part 200 Subpart F):

For additional information on single audit requirements for this program, review the current Compliance Supplement.

All HRSA awards are subject to the Uniform Administrative Requirements, Cost Principles, and Audit Requirements at 45 CFR part 75. HRSA awards are subject to the requirements of the HHS Grants Policy Statement (HHS GPS) that are applicable based on recipient type and purpose of award. The HHS GPS is available at https://www.hhs.gov/sites/default/files/hhs-grants-policy-statement-october-2024.pdf.

1. Social Security Act, Title V, Section 502(a)(1) and (b)(1), as amended; 42 U.S.C. 702.; Sections 1109, 1110, 1111 and 1112 of the Public Health Service Act and Section 399T of the Public Health Service Act; Public Health Service Act, § 330M (42 U.S.C. § 254c-19), as amended; 42 U.S.C. 254c-21 (Public Health Service Act, Title III Section 330O); 42 U.S.C. § 701(a)(2) (Title V, § 501(a)(2) of the Social Security Act).